ATE319734T1 - Steroidale verbindungen zur inhibierung von steroidsulfatasen - Google Patents

Steroidale verbindungen zur inhibierung von steroidsulfatasen

Info

Publication number: ATE319734T1
Authority: AT; Austria
Prior art keywords: group; steroidal compounds; inhibiting steroid; sulfatases; steroid sulfatases
Prior art date: 2001-10-18

Application number

AT02801418T

Other languages

English (en)

Inventor

Barry V L Potter

Michael J Reed

Lok Wai L Woo

Original Assignee

Sterix Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-18

Filing date

2002-10-17

Publication date

2006-03-15

2001-10-18 Priority claimed from PCT/GB2001/004645 external-priority patent/WO2002032409A2/en

2001-10-18 Priority claimed from GB0125073A external-priority patent/GB0125073D0/en

2002-04-23 Priority claimed from GB0209274A external-priority patent/GB0209274D0/en

2002-10-17 Application filed by Sterix Ltd filed Critical Sterix Ltd

2006-03-15 Application granted granted Critical

2006-03-15 Publication of ATE319734T1 publication Critical patent/ATE319734T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT02801418T 2001-10-18 2002-10-17 Steroidale verbindungen zur inhibierung von steroidsulfatasen ATE319734T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
PCT/GB2001/004645 WO2002032409A2 (en)	2000-10-20	2001-10-18	Use of compound in the manufacture of a pharmaceutical for inhibiting steroid sulphatase and steroid dehydrogenase activity
GB0125073A GB0125073D0 (en)	2001-10-18	2001-10-18	Compound
GB0209274A GB0209274D0 (en)	2002-04-23	2002-04-23	Compound

Publications (1)

Publication Number	Publication Date
ATE319734T1 true ATE319734T1 (de)	2006-03-15

Family

ID=27256082

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02801418T ATE319734T1 (de)	2001-10-18	2002-10-17	Steroidale verbindungen zur inhibierung von steroidsulfatasen

Country Status (6)

Country	Link
EP (1)	EP1448592B1 (de)
JP (1)	JP4553586B2 (de)
AT (1)	ATE319734T1 (de)
DE (1)	DE60209811T2 (de)
PT (1)	PT1448592E (de)
WO (1)	WO2003033518A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE453660T1 (de) *	2006-02-17	2010-01-15	Janssen Pharmaceutica Nv	17-phosphor-steroid-derivate als progesteron- rezeptormodulatoren
WO2007098381A2 (en) *	2006-02-17	2007-08-30	Janssen Pharmaceutica N.V.	11-phosphorous steroid derivatives useful as progesterone receptor modulators
GB0604142D0 (en) *	2006-03-01	2006-04-12	Sterix Ltd	Compound
US20100204146A1 (en)	2007-09-17	2010-08-12	Preglem S.A.	Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
EP2149371A1 (de)	2008-07-28	2010-02-03	PregLem S.A.	Verwendung von Steroid-Sulfatase-Hemmern zur Behandlung von Frühgeburtsleiden
CN104557602B (zh) *	2015-01-07	2016-08-17	华东师范大学	三环二萜衍生物及其制备方法、及其在制备抗肿瘤药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT314746B (de) *	1970-06-18	1974-04-25	Richter Gedeon Vegyeszet	Verfahren zur Herstellung von neuen D-Homo-imid-Derivaten mit Sterangerüst
GB9118478D0 (en) *	1991-08-29	1991-10-16	Imperial College	Steroid sulphatase inhibitors
US5755964A (en) *	1996-02-02	1998-05-26	The Dow Chemical Company	Method of treating polyamide membranes to increase flux
GB0025788D0 (en) *	2000-10-20	2000-12-06	Sterix Ltd	Use

2002
- 2002-10-17 JP JP2003536257A patent/JP4553586B2/ja not_active Expired - Fee Related
- 2002-10-17 PT PT02801418T patent/PT1448592E/pt unknown
- 2002-10-17 AT AT02801418T patent/ATE319734T1/de active
- 2002-10-17 EP EP02801418A patent/EP1448592B1/de not_active Expired - Lifetime
- 2002-10-17 DE DE60209811T patent/DE60209811T2/de not_active Expired - Lifetime
- 2002-10-17 WO PCT/GB2002/004686 patent/WO2003033518A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2003033518A1 (en)	2003-04-24
EP1448592B1 (de)	2006-03-08
EP1448592A1 (de)	2004-08-25
DE60209811T2 (de)	2006-10-12
JP2005506359A (ja)	2005-03-03
PT1448592E (pt)	2006-07-31
JP4553586B2 (ja)	2010-09-29
DE60209811D1 (de)	2006-05-04

Similar Documents

Publication	Publication Date	Title
CY1109130T1 (el)	2014-07-02	Οιστρογονου-17-σουλφαμικα ως αναστολεις σουλφατασης στεροειδους
KR100322650B1 (ko)	2002-03-20	에스트로겐 생성을 조절하는데 사용하기 위한 환 시스템화합물을 포함하는 약제학적 조성물
MXPA05010339A (es)	2005-12-14	Derivados de estrogeno como inhibidores de la esteroide sulfatasa.
TR200101893T2 (tr)	2001-11-21	Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler.
MXPA04003886A (es)	2004-07-08	Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
BR0111780A (pt)	2003-05-13	Agente herbicida
DK0918776T3 (da)	2004-07-12	Totalsyntese af antitumor acylfulvener
ES2177058T3 (es)	2002-12-01	Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p.
NO20002676L (no)	2000-05-25	Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
ATE319734T1 (de)	2006-03-15	Steroidale verbindungen zur inhibierung von steroidsulfatasen
MX2008011292A (es)	2008-09-10	Compuestos esteroidales como inhibidores de esteroide sulfatasa.
YU34799A (sh)	2002-11-15	Efikasna sinteza furan sulfonamid jedinjenja primenljivih u sintezi novih il-1 inhibitora
ATE408615T1 (de)	2008-10-15	Steroidale verbindungen zur hemmung von steroid sulfotase
ES2190781T3 (es)	2003-08-16	Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
DE60124519D1 (de)	2006-12-28	Trihydroxybenzen zur verhinderung der korrosion von titan
CA2419463A1 (en)	2002-03-07	Primary intermediates for oxidative coloration of hair
MY120189A (en)	2005-09-30	Sultam and sultone derived oxazolidinones
ES2067388A1 (es)	1995-03-16	Procedimiento para la produccion de derivados de piroglutamato de configuracion 2,4-cis
ECSP982576A (es)	1999-02-11	Derivados de epotilona
ES2187987T3 (es)	2003-06-16	Procedimiento para la preparacion de derivados 1,3-diaza-espirol(4,4)n0n-1-en-4-onicos y de intermedios 1-ciano-1-acilamino-ciclopentanicos.

Legal Events

Date

Code

Title

Description

2006-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1448592

Country of ref document: EP